Advancing Innovation, Inclusion and Impact: ACTRIS at SCRI Clinical Trials Symposium 2026
Topics
Events
5 August 2026
ACTRIS participated in the SCRI Clinical Trials Symposium 2026, joining discussions on the future of clinical trials and engaging the wider clinical research community.
Last week, ACTRIS participated in the SCRI Clinical Trials Symposium 2026, themed "Clinical Trials Reimagined: Advancing Innovation, Inclusion and Impact."
Over two days, the symposium brought together regulators, industry leaders and clinicians to explore the next era of clinical research, where smarter technologies, inclusive trial design and global partnerships converge to deliver better outcomes for patients. Discussions spanned real-world evidence, cross-sector collaboration and strategies to strengthen Asia-Pacific as a global trial hub.
Our Chief Medical Officer, Adj A/Prof Eng Soo Yap (opens in new tab), shared ACTRIS's perspective on the panel session "Trials that Matter: Aligning Clinical Research with Health System and Societal Needs". Moderated by A/Prof Jimmy Lee (opens in new tab), the session with A/Prof Yew Yoong Ding explored how clinical research can generate meaningful evidence and deliver greater impact for patients and health systems. It underscored the value of designing trials that address real health needs and policy priorities, and that translate into tangible benefits for patients.
The symposium was also a valuable opportunity to introduce ACTRIS to the wider clinical research community at our booth. We enjoyed sharing more about our work and capabilities as Singapore's national cell and gene therapy manufacturing platform, and appreciated the many conversations with researchers, clinicians, and industry partners on how we can collaborate to advance translational research and cell and gene therapy development. These interactions reinforced the importance of continued collaboration in accelerating the journey from scientific discovery to patient care.
Congratulations to our sister programme, Singapore Clinical Research Institute (SCRI) (opens in new tab), on 30 years of strengthening clinical research in Singapore, and on another successful symposium. We look forward to the continued growth of Singapore’s clinical research ecosystem in the years ahead.
